To assess the risks associated with development of CAS after prenatal MMC repair STUDY DESIGN: We conducted a retrospective cohort study of patients who underwent open or fetoscopic prenatal MMC repair from December 2011-May 2018. Open repair technique was performed as reported in the MOMS Trial. Fetoscopic repair was performed using uterine CO 2 insufflation, two or three ports, and an exteriorized uterus. Perinatal outcomes of patients who developed CAS after prenatal MMC repair were compared with those of patients who did not develop CAS. Degree of CAS was classified as mild if CAS occupied <25% of uterine surface area, moderate if 25-50%, or severe if >50%. Comparisons between cases with and without CAS were performed using Student's t-test, Chi-square, or Fisher's exact test. Logistic regression analysis was used to determine risk of developing CAS, PPROM, or preterm delivery. RESULTS: Of 73 patients who underwent prenatal MMC repair, 24 (32.9%) developed CAS. CAS was detected at median of 28.9 (25.4 e 37.6) weeks gestation and 4 (0.4 e 12.6) weeks post-surgery. 70.8% of CAS cases were identified after fetoscopic repairs and 29.2% after open repairs (p¼0.05). Development of CAS after fetoscopic repairs was independent of number of ports (3 ports: 35.3% vs. 2 ports: 64.7%; p¼0.7) or maximal uterine pressure used (CAS: 11.9AE1.7 mmHg vs. no CAS: 11.8AE1.9 mmHg; p¼0.7).
OBJECTIVE:
To assess the risks associated with development of CAS after prenatal MMC repair STUDY DESIGN: We conducted a retrospective cohort study of patients who underwent open or fetoscopic prenatal MMC repair from December 2011-May 2018. Open repair technique was performed as reported in the MOMS Trial. Fetoscopic repair was performed using uterine CO 2 insufflation, two or three ports, and an exteriorized uterus. Perinatal outcomes of patients who developed CAS after prenatal MMC repair were compared with those of patients who did not develop CAS. Degree of CAS was classified as mild if CAS occupied <25% of uterine surface area, moderate if 25-50%, or severe if >50%. Comparisons between cases with and without CAS were performed using Student's t-test, Chi-square, or Fisher's exact test. Logistic regression analysis was used to determine risk of developing CAS, PPROM, or preterm delivery. RESULTS: Of 73 patients who underwent prenatal MMC repair, 24 (32.9%) developed CAS. CAS was detected at median of 28.9 (25.4 e 37.6) weeks gestation and 4 (0.4 e 12.6) weeks post-surgery. 70.8% of CAS cases were identified after fetoscopic repairs and 29.2% after open repairs (p¼0.05). Development of CAS after fetoscopic repairs was independent of number of ports (3 ports: 35.3% vs. 2 ports: 64.7%; p¼0.7) or maximal uterine pressure used (CAS: 11.9AE1.7 mmHg vs. no CAS: 11.8AE1.9 mmHg; p¼0.7).
Four variables were assessed for increased risk of developing CAS. Anterior placenta was the only variable with significant predictive value (p¼0.03; OR: 3.23, 95% CI: 1.1-18.2). Fetoscopic repair, duration of surgery >3 hours, and use of three ports did not significantly increase risk of developing CAS.
Cases with CAS developed PPROM 5.2 times more frequently than cases without CAS (95% CI:1.5-18.3; p<0.01). Cases of PPROM preceded by CAS occurred at later gestational age than those not preceded by CAS. A trend was noted for an association between CAS and placental abruption. When cases of moderate or severe CAS (n¼11) were compared with mild CAS cases (n¼12; severity of 1 case could not be assessed) at time of diagnosis, a trend for longer interval between CAS and delivery was observed in mild cases [7.8 (1.3-12.28) weeks vs. 2 (0.1-13.2 weeks); p¼0.02]. CONCLUSION: Development of CAS increases the risk of adverse perinatal events. Efforts should be taken to reduce its incidence after prenatal MMC repair.
212 Cardiac parameters for prediction of coractation of the aorta (CoA) using fetal echocardiography Won-Kyu Jang, Joohee Lee, Mi-Young Lee, Hye-Sung Won, Jae-Yoon Shim, Pil-Ryang Lee Asan medical center, Song-pa Gu, Seoul, Korea (Republic of) OBJECTIVE: To determine which combination of cardiac parameters provides the best prediction of coarctation of the aorta (CoA) using fetal echocardiography. STUDY DESIGN: We retrospectively analyzed fetal cases prenatally diagnosed with CoA between January 2013 and December 2016 at Asan Medical Center. CoA was prenatally diagnosed when CoA shelf and hypoplasia of the isthmus < Z-score -2 were observed on three vessel view (3VV) or sagittal view. The following parameters measured by fetal echocardiography were analyzed: 1) tricuspid/mitral valve ratio (TV/MV); 2) right/left ventricle ratio (RV/LV); 3) pulmonary/ aortic valve ratio (PV/AV); 4) aortic valve (AV) Z-score; 5) ascending aorta (AA) Z-score; 6) pulmonary artery/AA ratio (PA/AA) on 3VV; and 7) aortic isthmus Z-score on 3VV and sagittal view. Fetuses with ventricular septal defect (VSD) or persistent left superior vena cava (PLSVC) were included. CoA was confirmed by postnatal echocardiography, computed tomography, or cardiac surgery. RESULTS: Among the 71 fetuses diagnosed with CoA, 32 were postnatally confirmed with CoA, and 39 were postnatally confirmed with normal heart. Median gestational ages (GA) at diagnosis of fetuses with CoA and normal fetuses were 26.07AE3.89 and 28.65AE3.98 weeks, respectively. Diagnostic rate was significantly higher when the fetus was diagnosed at earlier GA. All cardiac parameters except TV/MV and RV/ LV showed positive correlation with CoA. PV/AV and PA/AA were higher in fetuses with CoA than in normal fetuses. Z-score of AV, AA, ajog.org Poster Session I Supplement to JANUARY 2019 American Journal of Obstetrics & Gynecology S153
